Suppr超能文献

开发和验证用于卟啉症实验室诊断的诊断算法。

Development and validation of diagnostic algorithms for the laboratory diagnosis of porphyrias.

机构信息

Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.

Center of Metabolic Diseases, University Hospitals Leuven, Leuven, Belgium.

出版信息

J Inherit Metab Dis. 2022 Nov;45(6):1151-1162. doi: 10.1002/jimd.12545. Epub 2022 Aug 26.

Abstract

Porphyrias are rare metabolic disorders of the haem synthesis. They can present with acute neurovisceral attacks, cutaneous symptoms, or a combination of both. As they present with a wide variety of clinical symptoms, diagnosis is often delayed and correct interpretation of porphyria-related tests remains a challenge for many physicians. We developed and validated two algorithms for the laboratory diagnosis of porphyrias based on presenting symptoms. Based on a literature search and clinical/laboratory expertise, we developed algorithms for acute and cutaneous porphyrias. We validated these algorithms using all porphyria related laboratory test requests between January 1st 2000 and September 30th 2020 in UZ Leuven. In addition, we also evaluated our algorithm using samples from the European porphyria network (EPNET) external quality assessment scheme (2010-2021). Sensitivity of the algorithm for acute porphyria was 100.0% [74.9%-100.0%] (13 acute intermittent porphyria (AIP) and 1 variegate porphyria [VP]) with a specificity of 98.5% [91.0%-100.0%] (65 patients). Sensitivity of the algorithm for cutaneous porphyria was 100% [95.1%-100.0%] (7 VP, 59 porphyria cutanea tarda (PCT), 23 erythropoietic protoporphyria (EPP), 2 X-linked erythropoietic protoporphyria [XLEPP]) with a specificity of 93.9% [82.9%-98.5%]. There were no diagnostic samples of other types of porphyria. The algorithms correctly identified 18 of the 19 EPNET porphyria cases. One of the two hereditary coproporphyria cases was missed. The algorithms for acute and cutaneous porphyria showed high sensitivity and specificity and can be used to aid the clinician in correctly interpreting the laboratory findings of porphyria-related tests.

摘要

卟啉症是一种罕见的血红素合成代谢紊乱。它们可以表现为急性神经内脏发作、皮肤症状,或两者兼有。由于它们表现出各种各样的临床症状,诊断常常被延误,许多医生正确解读与卟啉症相关的检查结果仍然具有挑战性。我们根据临床表现开发并验证了两种用于卟啉症实验室诊断的算法。我们根据文献检索和临床/实验室专业知识,为急性和皮肤卟啉症开发了算法。我们使用 2000 年 1 月 1 日至 2020 年 9 月 30 日期间 UZ Leuven 所有与卟啉症相关的实验室检测请求对这些算法进行了验证。此外,我们还使用欧洲卟啉症网络(EPNET)外部质量评估计划(2010-2021 年)的样本对我们的算法进行了评估。急性卟啉症算法的敏感性为 100.0%[74.9%-100.0%](13 例急性间歇性卟啉症(AIP)和 1 例杂合性卟啉症[VP]),特异性为 98.5%[91.0%-100.0%](65 例)。皮肤卟啉症算法的敏感性为 100%[95.1%-100.0%](7 例 VP、59 例迟发性皮肤卟啉症[PCT]、23 例红细胞生成性原卟啉症[EPP]、2 例 X 连锁红细胞生成性原卟啉症[XLEPP]),特异性为 93.9%[82.9%-98.5%]。没有其他类型卟啉症的诊断样本。算法正确识别了 19 例 EPNET 卟啉症病例中的 18 例。遗传性粪卟啉症漏诊 2 例。急性和皮肤卟啉症算法具有较高的敏感性和特异性,可用于帮助临床医生正确解读与卟啉症相关检测的实验室结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验